0000899243-22-021346.txt : 20220607
0000899243-22-021346.hdr.sgml : 20220607
20220607163316
ACCESSION NUMBER: 0000899243-22-021346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220606
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AHMED NADIM
CENTRAL INDEX KEY: 0001731193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39856
FILM NUMBER: 221001564
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cullinan Oncology, Inc.
CENTRAL INDEX KEY: 0001789972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813867811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-410-4650
MAIL ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Cullinan Management, Inc.
DATE OF NAME CHANGE: 20210107
FORMER COMPANY:
FORMER CONFORMED NAME: Cullinan Oncology, LLC
DATE OF NAME CHANGE: 20191001
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-06
0
0001789972
Cullinan Oncology, Inc.
CGEM
0001731193
AHMED NADIM
C/O CULLINAN ONCOLOGY, INC.
ONE MAIN STREET, SUITE 520
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Common Stock
2022-06-06
4
P
0
8090
12.40
A
8090
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.34 to $12.45. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Jeffrey Trigilio, Attorney-in-Fact
2022-06-07